Abstract Title:

A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease.

Abstract Source:

Circulation. 2007 Apr 10;115(14):1858-65. Epub 2007 Mar 26. PMID: 17389261

Abstract Author(s):

Qi Sun, Jing Ma, Hannia Campos, Susan E Hankinson, JoAnn E Manson, Meir J Stampfer, Kathryn M Rexrode, Walter C Willett, Frank B Hu

Article Affiliation:

Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA.


BACKGROUND: High consumption of trans fat has been linked to the risk of coronary heart disease (CHD). We assessed the hypothesis that higher trans fatty acid contents in erythrocytes were associated with an elevated risk of CHD in a nested case-control study among US women. METHODS AND RESULTS: Blood samples were collected from 32,826 participants of the Nurses' Health Study from 1989 to 1990. During 6 years of follow-up, 166 incident cases of CHD were ascertained and matched with 327 controls. Total trans fatty acid content in erythrocytes was significantly correlated with dietary intake of trans fat (correlation coefficient=0.44, P<0.01) and was associated with increased plasma low-density lipoprotein cholesterol (P for trend =0.06), decreased plasma high-density lipoprotein cholesterol concentrations (P for trend<0.01), and increased plasma low-density lipoprotein to high-density lipoprotein ratio (P for trend<0.01). After adjustment for age, smoking status, and other dietary and lifestyle cardiovascular risk factors, higher total trans fatty acid content in erythrocytes was associated with an elevated risk of CHD. The multivariable relative risks (95% confidence intervals) of CHD from the lowest to highest quartiles of total trans fatty acid content in erythrocytes were 1.0 (reference), 1.6 (0.7 to 3.6), 1.6 (0.7 to 3.4), and 3.3 (1.5 to 7.2) (P for trend<0.01). The corresponding relative risks were 1.0, 1.1, 1.3, and 3.1 (P for trend<0.01) for a total of 18:1 trans isomers and 1.0, 1.5, 2.5, and 2.8 (P for trend<0.01) for a total of 18:2 trans isomers. CONCLUSIONS: These biomarker data provide further evidence that high trans fat consumption remains a significant risk factor for CHD after adjustment for covariates.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.